Oslo, 30 May 2013 - PCI Biotech (PCIB) terminates the Market Maker agreement with Fondsfinans ASA. Fondsfinans will continue to act as market maker up to and including 31 July 2013.
For further information, please contact:
Bernt-Olav Røttingsnes
CFO
Email: bor@pcibiotech.no
Mobile +47 913 47 021
For further information, please contact:
Bernt-Olav Røttingsnes
CFO
Email: bor@pcibiotech.no
Mobile +47 913 47 021
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.